2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Cited by (1,000)

Items 401–500 of 1,000

1. Development and validation of a Brief Diet Quality Assessment Tool in the French-speaking adults from Quebec
   Jacynthe Lafrenière, S. Harrison, Danielle Laurin, Chantal Brisson, Denis Charles Talbot, Patrick Couture, Simone Lemieux, Benoı̂t Lamarche · 2019 · International Journal of Behavioral Nutrition and Physical Activity
2. Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: A Korean National Health and Nutrition Examination Survey study
   Su‐Jeong Hwang Shin, Dong Wook Shin, In Young Cho, Su‐Min Jeong, Hyein Jung · 2020 · European Journal of Preventive Cardiology
3. Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
   Chunyue Guo, Han Cao, Guangliang Shan, Wei Zhao, Han Zhang, Kaijun Niu, Ze Qin Cui, Naijun Tang, Kuo Liu, Li Pan et al. · 2021 · Annals of Translational Medicine
4. Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study
   Yongin Cho, Yujin Jeong, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, Young Ju Suh, So Hun Kim · 2021 · Atherosclerosis
5. Hypertriglyceridemia in young adults with a 22q11.2 microdeletion
   Christina Blagojevic, Tracy Heung, Sarah L. Malecki, Shengjie Ying, Sabrina Cancelliere, Robert Alexander Hegele, Anne S. Bassett · 2022 · European Journal of Endocrinology
6. Economic Burden of Not Complying with Canadian Food Recommendations in 2018
   Olivia K. Loewen, John Paul Ekwaru, A. Ohinmaa, Paul J. Veugelers · 2019 · Nutrients
7. Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression
   Tiffany R. Bellomo, Emily E. Bramel, Jiwoo Lee, Sarah Urbut, Alyssa Monica Flores, Zhi Yu, Satoshi Koyama, Buu Minh Thanh Truong, Sara Haidermota, Matthew Jeremiah Eagleton et al. · 2025 · Circulation
8. Effects of Statin Use for Primary Prevention among Adults Aged 75 Years and Older in the National Health Insurance Service Senior Cohort (2002–2015)
   Sun Young Kim, Hangseok Choi, Chang Won Won · 2020 · Annals of Geriatric Medicine and Research
9. Lp(a)‐Associated Oxidized Phospholipids in Healthy Black and White Participants in Relation to apo(a) Size, Age, and Family Structure
   Lars Berglund, Kyoungmi Kim, Wei Zhang, Nishant Prakash, Kevin Truax, Erdembileg Anuurad, Byambaa Enkhmaa · 2021 · Journal of the American Heart Association
10. Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry
    Gabrielle Roy, Patrick Couture, Jacques J. Genest, Isabelle L. Ruel, Alexis Wilfrid Baass, Jean Bergeron, Diane Brisson, Liam R. Brunham, Lubomira Cermakova, Daniel Gaudet et al. · 2021 · Canadian Journal of Cardiology
11. A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA)
    Alexandra Bastiany, Christine Pacheco, Tara Sedlak, Jaqueline Saw, Steven E.S. Miner, Shuangbo Liu, Andrea Lavoie, Daniel H. Kim, Martha Gulati, Michelle M. Graham · 2022 · CJC Open
12. Keto is Trending: Implications for Body Weight and Lipid Management
    Carol F. Kirkpatrick, Kaye-Eileen Willard, Kevin Carl Maki · 2022 · Current Cardiology Reports
13. Personalized prediction of incident hospitalization for cardiovascular disease in patients with hypertension using machine learning
    Yuanchao Feng, Alexander A. C. Leung, Xuewen Lu, Zhiying Liang, Hude Quan, Robin L. Walker · 2022 · BMC Medical Research Methodology
14. Lipid-lowering therapies for cardiovascular disease prevention and management in primary care
    Nicolas Dugré, Adrienne J. Lindblad, Danielle M. Perry, G. Allan, Emélie Braschi, Jamie Falk, Liesbeth S. Froentjes, Scott R. Garrison, J. Kirkwood, C. Korownyk et al. · 2023 · Canadian Family Physician Médecin de famille canadien
15. Multifunctional dietary interventions, low-grade inflammation and cardiometabolic profile: a scoping review
    Hugo Hornero‐Ramirez, Adrien Aubin, Marie‐Caroline Michalski, Sophie Vinoy, Cyrielle Caussy, Julie‐Anne Nazare · 2024 · Frontiers in Immunology
16. Prevention of Cardiovascular Disease Among Cancer Survivors: the Role of Pre-existing Risk Factors and Cancer Treatments
    Derek Rothe, Ian Paterson, Nanette Cox-Kennett, Gabor T. Gyenes, Edith Pituskin · 2017 · Current Epidemiology Reports
17. Effects of Preoperative Statin on Acute Kidney Injury After Off‐Pump Coronary Artery Bypass Grafting
    Jungchan Park, Jong‐Hwan Lee, Keoung Ah Kim, Seung Hwa Lee, Young Tak Lee, Wook Sung Kim, Jeong Jin Min · 2019 · Journal of the American Heart Association
18. Comparison of metabolic and antioxidant responses to a breakfast meal with and without pecans
    Alexis R. Marquardt, Kristina Lewandowski, Chad Michael Paton, Jamie A. Cooper · 2019 · Journal of Functional Foods
19. Measurement of lipid profiles in the early postpartum period after hypertensive disorders of pregnancy
    Chuan Wen, Amy Metcalfe, Todd J. Anderson, Jo-Ann Johnson, Ronald Jeremy Sigal, Kara A. Nerenberg · 2019 · Journal of clinical lipidology
20. Prolonged hyperlipidemia exposure increases the risk of arterial stiffness in young adults: a cross-sectional study in a cohort of Chinese
    Haojia Chen, Youren Chen, Weiqiang Wu, Zekai Chen, Zefeng Cai, Zhichao Chen, Xiuzhu Yan, Shouling Wu · 2020 · BMC Public Health
21. Sweet Potato Leaf Feeding Decreases Cholesterol, Oxidative Stress and Thrombosis Formation in Syrian Hamsters with a High-Cholesterol Diet
    Hao Chang, Yi-Chan Lan, Shiu‐Dong Chung, Chiang‐Ting Chien · 2021 · Life
22. Dietary Influences on Atherosclerotic Cardiovascular Disease Risk
    Carol F. Kirkpatrick, Kevin Carl Maki · 2021 · Current Atherosclerosis Reports
23. Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
    Ежов Марат Владиславович, Narek A. Tmoyan, Olga I. Afanasieva, Marina I. Afanasieva, Sergei N. Pokrovsky · 2021 · Biomolecules
24. Role of Phytoestrogen-Rich Bioactive Substances (Linum usitatissimum L., Glycine max L., Trifolium pratense L.) in Cardiovascular Disease Prevention in Postmenopausal Women: A Systematic Review and Meta-Analysis
    Agata Błaszczuk, Agnieszka Barańska, Wiesław Maciej Kanadys, Maria Malm, Monika Elżbieta Jach, Urszula Religioni, Rafał Wróbel, Jolanta Herda, Małgorzata Polz‐Dacewicz · 2022 · Nutrients
25. Apolipoprotein B in cardiovascular risk assessment
    Maud Ahmad, Allan D. Sniderman, Robert Alexander Hegele · 2023 · Canadian Medical Association Journal
26. Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022
    Blair J. MacDonald, Ricky D. Turgeon · 2023 · JAMA Network Open
27. Cumulative residual cholesterol predicts the risk of cardiovascular disease in the general population aged 45 years and older
    Mengjie Zhao, Mengli Xiao, Qin Tan, Jinjin Ji, Fang Ying Lu · 2024 · Lipids in Health and Disease
28. Artificial intelligence in coronary artery calcium score: rationale, different approaches, and outcomes
    Gennari, Antonio G., Rossi, Alexia, De Cecco, Carlo N., van Assen, Marly, Sartoretti, Thomas, Giannopoulos, Andreas A., Schwyzer, Moritz, Huellner, Martin W., Messerli, Michael · 2024 · The International Journal of Cardiovascular Imaging
29. Development and multinational validation of an algorithmic strategy for high Lp(a) screening
    Arya Aminorroaya, Lovedeep Singh Dhingra, Evangelos K. Oikonomou, Seyedmohammad Saadatagah, Phyllis Thangaraj, Sumukh Vasisht Shankar, Erica Sarah Spatz, Rohan Khera · 2024 · Nature Cardiovascular Research
30. Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures
    Valentina Scattolini, Camilla Luni, Alessandro Zambon, Silvia Galvanin, Onelia Gagliano, Catalin Dacian Ciubotaru, Angelo Avogaro, Fabio Mammano, Nicola Elvassore, Gian Paolo Fadini · 2016 · Diabetes Therapy
31. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis
    Antoni Sicras‐Mainar, Luis Sánchez-Alvarez, Ruth Navarro‐Artieda, Josep Darbà · 2018 · Lipids in Health and Disease
32. Impact of the Martin/Hopkins modified equation for estimating LDL-C on lipid target attainment in a high risk patient population
    Louis-Jacques Cartier, Simon St-Cœur, Alex Robin, Mathieu Lagacé, Pierre Douville · 2019 · Clinical Biochemistry
33. Nonfasting Lipids for All Patients?
    Zareen M. Farukhi, Samia Mora · 2020 · Clinical Chemistry
34. Challenges in Optimizing Lipid Management in Women
    Kellsey Peterson, Gurleen Kaur, Eugenia Gianos, Sulagna Mookherjee, Kim A. Poli, Mandeep S. Sidhu, Radmila Lyubarova · 2021 · Cardiovascular Drugs and Therapy
35. A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention
    D. Mitchell, J. Guertin, Anick Dubois, Marie-Pierre Dubé, J. Tardif, A. Iliza, Fiorella Fanton-Aita, A. Matteau, J. LeLorier · 2018 · Molecular Diagnosis & Therapy
36. Glycemic index is as reliable as macronutrients on food labels
    Thomas M. S. Wolever, Livia S. A. Augustin, Jennie Cecile Brand-Miller, Elizabeth Delport, Geoffrey Livesey, David S. Ludwig, John L. Sievenpiper · 2017 · American Journal of Clinical Nutrition
37. Low Density Lipoprotein (LDL) Cholesterol as a Causal Role for Atherosclerotic Disease: Potential Role of PCSK9 Inhibitors
    Rita Del Pinto, Davide Grassi, Giuliana Properzi, Giovambattista Desideri, Claudio Ferri · 2019 · High Blood Pressure & Cardiovascular Prevention
38. Chronic Kidney Disease and End Stage Renal Disease
    Dan J. Martinusen, Judith Marin, Elaine Cheng, Wynnie Lau · 2020 · Advanced clinical pharmacy - research, development and practical applications/Advanced clinical pharmacy - research, development and practical applications
39. Effects of vitamin D supplementation on apolipoprotein A1 and B100 levels in adults: Systematic review and meta-analysis of controlled clinical trials
    Nima Radkhah, Sakineh Shab‐Bidar, Meysam Zarezadeh, Abdolrasoul Safaeiyan, Ali Barzegar · 2021 · Journal of Cardiovascular and Thoracic Research
40. Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease
    Olga Iu. Mironova, Maria A. Isaikina, Sofiia A. Khasieva · 2021 · Terapevticheskii arkhiv
41. Study protocol for the sheMATTERS study (iMproving cArdiovascular healTh in new moThERS): a randomized behavioral trial assessing the effect of a self-efficacy enhancing breastfeeding intervention on postpartum blood pressure and breastfeeding continuation in women with hypertensive disorders of pregnancy
    Natalie Dayan, Graeme Neil Smith, Atanas Nedelchev, Haim Arie Abenhaim, Richard Nicolas Brown, Deborah Da Costa, Suhad Ali, Jesseca Perlman, Tuong Vi Nguyen, Cindy‐Lee Dennis et al. · 2023 · BMC Pregnancy and Childbirth
42. Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis
    Fatemeh Vazirian, Masoumeh Sadeghi, Theodoros Kelesidis, Matthew Jay Budoff, Zahra Zandi, Sara Samadi, Amir Hooshang Mohammadpour · 2023 · Nutrition Metabolism and Cardiovascular Diseases
43. Evidence supporting the choice of a new cardiovascular risk equation for Australia
    Sinan Brown, Emily Banks, Mark Woodward, Natalie Raffoul, Garry Jennings, Ellie Paige · 2023 · The Medical Journal of Australia
44. Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults
    Yuliang Xiang, Lei Gan, Heyue Du, Qiukui Hao, Bert Aertgeerts, Sheyu Li, Ming Hu · 2023 · International Journal of Technology Assessment in Health Care
45. Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments
    Maarten J.G. Leening, M. Arfan Ikram · 2018 · PLoS Medicine
46. Projected Real‐World Effectiveness of Using Aggressive Low‐Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada
    David Andrew Alter, Jack V. Tu, Maria Koh, Cynthia Anne Jackevicius, Peter C. Austin, Mohammad R. Rezai, R. Sacha Bhatia, Sharon Johnston, Jacob Allen Udell, Dennis T. Ko · 2018 · Journal of the American Heart Association
47. GOAL Canada: Physician Education and Support Can Improve Patient Management
    Anatoly Langer, Mary Tan, Shaun G. Goodman, Jean C. Grégoire, Peter Lin, G.B. John Mancini, James A. Stone, Cheryll Wills, Caroline Spindler, Lawrence A. Leiter · 2019 · CJC Open
48. Egyptian practical guidance in lipid management 2020
    Hesham Taha, Hala Mahfouz Badran, Hossam Kandil, Nabil Mahmoud Farag, Abbas Oraby, Magdy El Sharkawy, Khaled Shokry, Fouad Fawzy, Hossam A. Mahrous, Juliette Bahgat et al. · 2021 · The Egyptian Heart Journal
49. Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview
    Ioannis Parthymos, Michael S. Kostapanos, Dimitri P. Mikhailidis, Matilda Florentin · 2021 · European Journal of Preventive Cardiology
50. Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality
    Gil Lavie, Moshe Hoshen, Morton Leibowitz, Arriel Benis, Amichay Akriv, Ran D. Balicer, Orna Reges · 2020 · The American Journal of Medicine
51. Proportions of long-chain ω-3 fatty acids in erythrocyte membranes of Canadian adults: Results from the Canadian Health Measures Survey 2012–2015
    Isabelle Demonty, Kellie A. Langlois, Linda S. Greene-Finestone, Rana Zoka, Loan Nguyen · 2020 · American Journal of Clinical Nutrition
52. The Evolving Role of Artificial Intelligence in Cardiac Image Analysis
    Pascal Thériault-Lauzier, Robert Avram, Damini Dey, Piotr J. Slomka, Jonathan Afilalo, Benjamin J.W. Chow · 2021 · Canadian Journal of Cardiology
53. Managing dyslipidaemia for the primary prevention of cardiovascular disease
    Aidan Ryan, Simon Charles Heath, Paul R. Cook · 2018 · BMJ
54. Pregnancy-associated cardiovascular risks and postpartum care; an opportunity for interventions aiming at health preservation and disease prevention
    Nicole Wallin, Lina Bergman, Graeme Neil Smith · 2023 · Best Practice & Research Clinical Obstetrics & Gynaecology
55. Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab
    Antonio J. Vallejo‐Vaz, Lawrence A. Leiter, Stefano Del Prato, Marja‐Riitta Taskinen, Dirk Müller‐Wieland, Maja Bujas‐Bobanovic, Alexia Letierce, Jonas Mandel, Rita Samuel, Kausik Kumar Ray · 2020 · European Journal of Preventive Cardiology
56. Assessing the dyslipidemias: to fast or not to fast?
    Zareen M. Farukhi, Samia Mora · 2021 · Current Opinion in Endocrinology Diabetes and Obesity
57. Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study
    Kongyong Cui, Dong Yin, Cheng‐Gang Zhu, Sheng Yuan, Shaoyu Wu, Lei Feng, Kefei Dou · 2022 · Nutrition Metabolism and Cardiovascular Diseases
58. Nonfasting remnant cholesterol and cardiovascular disease risk prediction in Albertans: a prospective cohort study
    Olivia R. Weaver, Jacqueline A. Krysa, Ming Ye, Jennifer E. Vena, Dean T. Eurich, Spencer D. Proctor · 2023 · CMAJ Open
59. A higher non‐HDL‐C/HDL‐C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Jiamin Liu, Li Zhao, Yazhou Zhang, Lili Wang, Qianqian Feng, Jing Cui, Wenhong Zhang, Jianyong Zheng, Dan Wang, Fengjiao Zhao et al. · 2024 · Clinical Cardiology
60. The combination use of inclisiran and statins versus statins alone in the treatment of dyslipidemia in mainland China: a cost-effectiveness analysis
    Wenjing Zhou, Zhuoru Liang, Xiaohuan Lou, Nansong Wang, Xinyu Liu, Ruoxi Li, Pearl Pai · 2024 · Frontiers in Pharmacology
61. Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia
    Bilal Bashir, Maryam Ferdousi, Paul N. Durrington, Handrean Soran · 2024 · Current Opinion in Lipidology
62. Evaluation of microwave irradiated Polyacrylamide grafted Opuntia leaf mucilage graft copolymer (OPM-g-PAM) as effective controlled release polymer for release of Rosuvastastin as model drug
    Itishree Jogamaya Das, Shambhavi Kashyap, Karmabeer Jena, A. Sinha, Balaji Ayyanar Chinnappan, Sanjay Mavinkere Rangappa, Suchart Siengchin, Subhendu Chakroborty, Trishna Bal · 2024 · International Journal of Biological Macromolecules
63. Dyslipidaemia in the elderly: to treat or not to treat?
    Niki Katsiki, Genovefa D. Kolovou, Pablo Pérez‐Martínez, Dimitri P. Mikhailidis · 2018 · Expert Review of Clinical Pharmacology
64. Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?
    Katrina L. Ellis, Gerald Francis Watts · 2018 · Cardiology Clinics
65. Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II—clinical practice guideline appraisal for lipid management in coronary heart disease
    Huimin Zhou, Shaozhao Zhang, Xiuting Sun, Da-Ya David Yang, Xiaodong Zhuang, Yue Guo, Xun Yang Hu, Zhimin Du, Meifen Zhang, Xinxue Liao · 2019 · Journal of Thoracic Disease
66. Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment
    Monica Zolezzi, Oraib Abdallah, Sowndramalingam Sankaralingam · 2020 · Risk Management and Healthcare Policy
67. Coronary CT Angiography Guided Medical Therapy in Subclinical Atherosclerosis
    Alyssa L. S. Chow, Saad Alhassani, Andrew Michael Crean, Gary R. Small · 2021 · Journal of Clinical Medicine
68. Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®)
    Xavier Pintó, L. Masana, Fernando Civeira, José Manuel Fernández‐Real, Daiana Ibarretxe, Beatriz Candás‐Estébanez, José Puzo, José Luis Díaz-Díaz, Núria Amigó, Margarita Esteban et al. · 2020 · Clínica e Investigación en Arteriosclerosis (English Edition)
69. Factors affecting creatine phosphokinase elevation during daptomycin therapy using a combination of machine learning and conventional methods
    Shungo Imai, Hitoshi Kashiwagi, Yuki Sato, Takayuki Miyai, Mitsuru Sugawara, Yoh Takekuma · 2021 · British Journal of Clinical Pharmacology
70. Statins for primary prevention among elderly men and women
    Maria Bergami, Edina Cenko, Jinsung Yoon, Guiomar Mendieta, Sasko A. Kedev, Marija D. Zdravkovic, Zorana Vasiljević, Davor Miličić, Olivia Manfrini, Mihaela van der Schaar et al. · 2021 · Cardiovascular Research
71. Modifiable Risk Factors and Residual Risk Following Coronary Revascularization
    Trevor Simard, Richard G. Jung, Pietro Di Santo, David T. Harnett, Omar Abdel‐Razek, Francisco Daniel Ramirez, Pouya Motazedian, Simon Parlow, Alisha Labinaz, Robert Moreland et al. · 2021 · Mayo Clinic Proceedings Innovations Quality & Outcomes
72. Lipoprotein(a): Role in atherosclerosis and new treatment options
    Dragana Tomić-Naglić, Mia S. Manojlovic, Sladjana Pejaković, Kristina Stepanović, Jovana Prodanović · 2023 · Biomolecules and Biomedicine
73. Quality of care for cardiovascular disease prevention in rheumatoid arthritis: compliance with hyperlipidemia screening guidelines
    Timothy J. Schmidt, Juan Antonio Aviña-Zubieta, Eric C. Sayre, Michał Abrahamowicz, John M. Esdaile, Diane V. Lacaille · 2018 · Lara D. Veeken
74. Pediatric reference intervals for calculated LDL cholesterol, non-HDL cholesterol, and remnant cholesterol in the healthy CALIPER cohort
    Victoria Higgins, Shervin Asgari, Man Khun Chan, Khosrow Adeli · 2018 · Clinica Chimica Acta
75. Comprehensive laboratory reference intervals for routine biochemical markers and pro‐oxidant‐antioxidant balance (PAB) in male adults
    Hamideh Ghazizadeh, Mary Kathryn Bohn, Roshanak Ghaffarian Zirak, Atieh Kamel Khodabandeh, Reza Zare‐Feyzabadi, Maryam Saberi‐Karimian, Ameneh Timar, Naghmeh Jaberi, Maryam Mohammadi‐Bajgiran, Payam Sharifan et al. · 2020 · Journal of Clinical Laboratory Analysis
76. Network Medicine Approach in Prevention and Personalized Treatment of Dyslipidemias
    Giuditta Benincasa, Paola de Candia, Dario Costa, Mario Faenza, Gelsomina Mansueto, Giuseppe Ambrosio, Claudio Napoli A · 2020 · Lipids
77. A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey
    Li Geng, Li Zhou, Wenwei Ouyang, Meiling Xuan, Liming Lu, Xiaoyan Li, Zehuai Wen, Xiankun Chen · 2019 · Trials
78. British Columbia CARMA-CHIWOS Collaboration (BCC3): protocol for a community-collaborative cohort study examining healthy ageing with and for women living with HIV
    Shayda A. Swann, Angela Kaida, Valerie Nicholson, Jason C. Brophy, Amber R Campbell, Allison Carter, Chelsea N. Elwood, Tsion Gebremedhen, Rebecca Gormley, Elizabeth M. King et al. · 2021 · BMJ Open
79. Age‐Related Associations of Low‐Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population‐Based Cohort Study
    Han Na Jung, Minju Kim, Hwi Seung Kim, Woo Je Lee, Se Hee Min, Ye‐Jee Kim, Chang Hee Jung · 2022 · Journal of the American Heart Association
80. Elevated Lp(a) Levels Correlate with Severe and Multiple Coronary Artery Stenotic Lesions
    Cynthia Al Hageh, Stéphanie Chacar, Michella Ghassibe‐Sabbagh, Daniel E. Platt, Andreas Henschel, Hamdan Hamdan, Dominique Gauguier, Yara El Murr, Eman A. Alefishat, Elie Chammas et al. · 2023 · Vascular Health and Risk Management
81. Exploring the role of lipoprotein(a) in cardiovascular diseases and diabetes in Chinese population
    Zubair Butt Hussain, Junaid Iqbal, Hongcai Liu, Hou‐De Zhou · 2023 · International Journal of Biological Macromolecules
82. Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists
    Hazal E. Babadagli, Arden R. Barry, George Thanassoulis, Glen J. Pearson · 2023 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
83. Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population‐Based Cohort Study
    Bisan Shweikialrefaee, Dennis T. Ko, Jiming Fang, Andrea Pang, Peter C. Austin, Paul Dorian, Sheldon M. Singh, Cynthia Anne Jackevicius, Karen Tu, Douglas S. Lee et al. · 2023 · Journal of the American Heart Association
84. Women's Knowledge of Future Cardiovascular Risk Associated With Complications of Pregnancy: A Systematic Review
    Gabriela Lima de Melo Ghisi, Laura Banks, Lisa M. Cotie, Maureen T. Pakosh, Courtney L. Pollock, Kara A. Nerenberg, Anna R. Gagliardi, Graeme Neil Smith, Tracey J. F. Colella · 2023 · CJC Open
85. Prevalence and management of dyslipidemia in primary care practices in Canada
    Olivia Spohn, Rachael Morkem, Alexander G. Singer, David Barber · 2024 · Canadian Family Physician
86. Effect of nut consumption on blood lipids: An updated systematic review and meta-analysis of randomized controlled trials
    Stephanie K. Nishi, Indira Paz‐Graniel, Jiaqi Ni, Cristina Valle‐Hita, Nadine Khoury, Jesús Francisco García-Gavilán, Nancy Babió, Jordi Salas‐Salvadó · 2024 · Nutrition Metabolism and Cardiovascular Diseases
87. Incidence and magnitude of post‐transplant cardiovascular disease after pediatric kidney transplantation: Risk factor analysis of 1058 pediatric kidney transplants at the university of Minnesota
    Oscar Kenneth Serrano, Ananta Shrikant Bangdiwala, David M. Vock, Srinath Chinnakotla, Ty B. Dunn, Erik B. Finger, Raja Kandaswamy, Timothy L. Pruett, John S. Najarian, Arthur J. Matas et al. · 2018 · Pediatric Transplantation
88. Awareness of physicians and clinical pharmacists about ACC/AHA guidelines for dyslipidemia management: A cross sectional study
    YasirAhmed Ibrahim, Mohammad F. Zaitoun, MaisHasan Iflaifel, LoloahAbdullah Almulhim, MohammedAli Al-Ghamdi · 2019 · Journal of Pharmacy And Bioallied Sciences
89. The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
    Weifeng Xu, Haiwang Guan, Da Gao, Zicheng Wang, Yanna Ba, Hao Yang, Wenjun Shen, Jiangfang Lian, Jian Zhou · 2020 · Diabetes Metabolic Syndrome and Obesity
90. Comparison of original and modified Q risk 2 risk score with Framingham risk score - An Indian perspective
    Puneet Aggarwal, Santosh Kumar Sinha, Dibbendhu Khanra, Ranjit Kumar Nath, Jaskaran Singh Gujral, Nageshwar Venkatesh Reddy, Anindya Mukherjee · 2021 · Indian Heart Journal
91. Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology
    Michael M. Page, Gerald Francis Watts · 2021 · Current Opinion in Cardiology
92. A Web-Based Health Application to Translate Nutrition Therapy for Cardiovascular Risk Reduction in Primary Care (PortfolioDiet.app): Quality Improvement and Usability Testing Study
    Meaghan E Kavanagh, Laura Chiavaroli, Andrea J Glenn, Genevieve Heijmans, Shannan Grant, Chi-Ming Chow, Robert G. Josse, Vasanti Malik, William Watson, Aïsha Lofters et al. · 2022 · JMIR Human Factors
93. Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
    Jeongmin Lee, Seung‐Hwan Lee · 2023 · The Korean Journal of Internal Medicine
94. The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia
    Liam R. Brunham, Kelsey Lynch, Amy English, Rory Sutherland, Jian Weng, Raymond Cho, Graham Christopher Wong, Aslam Hayat Anis, Gordon A. Francis, Nadia A. Khan et al. · 2018 · Clinical Cardiology
95. Statin Use and Chronic Lymphocytic Leukemia Incidence: A Nested Case–Control Study in Manitoba, Canada
    Christiaan H. Righolt, Geng Zhang, Xibiao Ye, Versha Banerji, James B. Johnston, Spencer Bruce Gibson, Salaheddin M. Mahmud · 2019 · Cancer Epidemiology Biomarkers & Prevention
96. Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study
    Shuo-Lin Liu, Na‐Qiong Wu, Yuan‐Lin Guo, Cheng‐Gang Zhu, Ying Gao, Jing Sun, Rui‐Xia Xu, Geng Liu, Qian Dong, Jian‐Jun Li · 2019 · Postgraduate Medical Journal
97. Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin
    Jo Jo Hai, Yuen‐Kwun Wong, Chun‐Ka Wong, Ka‐Chun Un, Pak‐Hei Chan, Chung‐Wah Siu, Kai‐Hang Yiu, Chu‐Pak Lau, Hung‐Fat Tse · 2019 · BMC Cardiovascular Disorders
98. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
    Michel R. Langlois, Børge Grønne Nordestgaard, Anne Langsted, M. John Chapman, Kristin Moberg Aakre, Hannsjörg H.E. Baum, Jan Borén, Éric Bruckert, Alberico Luigi Catapano, Christa M. Cobbaert et al. · 2021 · Laboratory Service
99. An Appetite for Modernizing the Regulatory Framework for Protein Content Claims in Canada
    Christopher P. F. Marinangeli, Samara Foisy, Anna Kate K Shoveller, Cara Porter, Kathy Musa‐Veloso, John L. Sievenpiper, David J.A. Jenkins · 2017 · Nutrients
100. Treatment Inertia in Patients With Familial Hypercholesterolemia
     Anatoly Langer, G.B. John Mancini, Mary Tan, Shaun G. Goodman, Vineeta Ahooja, Jean C. Grégoire, Peter Lin, James A. Stone, Lawrence A. Leiter · 2021 · Journal of the American Heart Association